Importance of surrogate markers in evaluation of antiviral therapy for HIV infection

被引：13

|

作者：

Deyton, L

机构：

[1] Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD

来源：

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 1996年 / 276卷 / 02期

关键词：

D O I：

10.1001/jama.276.2.159

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

收藏

页码：159 / 160

页数：2

相关论文

共 50 条

[11] ANTIVIRAL THERAPY FOR HIV-INFECTION IN INFANTS AND CHILDREN
GERSHON, AA
PEDIATRIC AIDS: CLINICAL, PATHOLOGIC, AND BASIC SCIENCE PERSPECTIVES, 1993, 693 : 166 - 177
[12] ANTIVIRAL THERAPY IN HIV-INFECTION - PRACTICAL GUIDELINES
PARA, MF
CLEVELAND CLINIC JOURNAL OF MEDICINE, 1994, 61 (01) : 76 - 77
[13] HIV SURROGATE MARKERS WEIGHED
COTTON, P
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 265 (11): : 1357 - +
[14] Surrogate markers in HIV disease
Peto, T
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1996, 37 : 161 - 170
[15] MARKERS FOR PROGRESSION TO AIDS DURING NATURAL INFECTION AND ANTIVIRAL THERAPY
GOUDSMIT, J
DEWOLF, F
PATHOLOGIE BIOLOGIE, 1991, 39 (09): : 873 - 873
[16] ANTIVIRAL THERAPY IN HIV PEDIATRIC INFECTION - ACTUAL MANAGEMENT AND FUTURE
BLANCHE, S
MEDECINE ET MALADIES INFECTIEUSES, 1990, 20 (8-9): : 453 - 453
[17] Use of surrogate markers for drugs of military importance
Marino, MT
MILITARY MEDICINE, 1998, 163 (11) : 743 - 746
[18] Evaluation of longitudinal surrogate markers
Agniel, Denis
Parast, Layla
BIOMETRICS, 2021, 77 (02) : 477 - 489
[19] Antiviral treatment of HIV infection
Thomas, MG
Ellis-Pegler, RB
NEW ZEALAND MEDICAL JOURNAL, 1998, 111 (1074) : 353 - 354
[20] The Use of Nonhuman Primate Models of HIV Infection for the Evaluation of Antiviral Strategies
Van Rompay, Koen K. A.
AIDS RESEARCH AND HUMAN RETROVIRUSES, 2012, 28 (01) : 16 - 35

← 1 2 3 4 5 →